How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
about
Evidence-Based Treatments for Adults with MigraineTriptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.Almotriptan and zolmitriptan in the acute treatment of migraine.Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.Randomised controlled trial of food elimination diet based on IgG antibodies for the prevention of migraine like headaches.Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.Clinical profile and practice experience of almotriptan.Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.Pathways to the best fit of triptans for migraine patients.The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.Almotriptan: a review of 10 years' clinical experience.Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.Interaction between ketoconazole and almotriptan in healthy volunteers.Determining triptan preference for the individual patient.Multiple attack study on the available triptans in Italy versus placebo.
P2860
Q26769968-FF70FE23-E69A-4F00-8F5F-1362ACAAFB35Q34154647-C15FBF88-F292-4E8D-B4E8-F52F0601F146Q34573136-D38C8189-FF89-49E2-9A2C-0E5C30120D2AQ35116532-9E4C2BF2-7EE2-4970-90CD-DEAD3840DA29Q35426749-473789CC-3A8A-426D-B59A-CBA50B4BEA47Q35779019-FD1792F2-032E-41AD-B36E-5D27AF2BFCEFQ35982145-C7B6027A-EDDF-4BD6-9DD1-6E41FD0A0667Q36373560-53E445FF-3B87-4524-9325-90EB23F79E21Q36947155-7EC6B8B9-F7D8-48DC-A146-DA18E7A07C7EQ37247869-68C77A55-D442-46C0-8855-4F876F2CB020Q37247876-DDA1D202-3585-4A62-B59F-BA88BFCBA2A6Q37800072-B45C1E07-92DC-4342-8238-73744E6C92D1Q39339602-BA946741-84D5-45C3-937D-A8028B9241CBQ39365280-57B8DD53-D3B2-472E-A11E-D39B413DB15DQ39365816-38707474-473C-4994-B8D2-DA567050AFA7Q41300169-57143DDB-7417-46C4-9CE1-8BF3B82D4169Q44424388-3C8FBE7D-B5C1-4606-A2A6-BDF5CEC2B8ECQ44946357-E5520C9F-35F3-4933-B26B-FDC571FACE52Q46548647-440EB5D5-14A9-41BA-9C1E-89166C8A1DB2
P2860
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
How does almotriptan compare w ...... bo-controlled clinical trials.
@ast
How does almotriptan compare w ...... bo-controlled clinical trials.
@en
type
label
How does almotriptan compare w ...... bo-controlled clinical trials.
@ast
How does almotriptan compare w ...... bo-controlled clinical trials.
@en
prefLabel
How does almotriptan compare w ...... bo-controlled clinical trials.
@ast
How does almotriptan compare w ...... bo-controlled clinical trials.
@en
P2093
P2860
P1433
P1476
How does almotriptan compare w ...... bo-controlled clinical trials.
@en
P2093
Andrew J Dowson
Carl G H Dahlöf
Julio Pascual
P2860
P304
P356
10.1046/J.1526-4610.2002.02025.X
P577
2002-02-01T00:00:00Z